about
Coronary heart disease risk factors and outcomes in the twenty-first century: findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) StudyA PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients.Effect of the look AHEAD study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with type 2 diabetes.Antihypertensive medications and sexual function in women: baseline data from the SBP intervention trial (SPRINT).Is pulse pressure an independent risk factor for incident acute coronary heart disease events? The REGARDS study.Secular changes in rates of coronary heart disease, fatal coronary heart disease, and out-of-hospital fatal coronary heart diseaseComparison of Postprandial Responses to a High-Fat Meal in Hypertriglyceridemic Men and Women before and after Treatment with Fenofibrate in the Genetics and Lipid Lowering Drugs and Diet Network (GOLDN) Study.Statin underuse and low prevalence of LDL-C control among U.S. adults at high risk of coronary heart disease.Angiotensin converting enzyme inhibitors: are they preferred first-line therapy?Declines in coronary heart disease incidence and mortality among middle-aged adults with and without diabetesThe association of statin use and statin type and cognitive performance: analysis of the reasons for geographic and racial differences in stroke (REGARDS) study.Objective sleep, a novel risk factor for alterations in kidney function: the CARDIA studyIs funding source related to study reporting quality in obesity or nutrition randomized control trials in top-tier medical journals?Long-acting diltiazem HCl for the chronotherapeutic treatment of hypertension and chronic stable angina pectoris.Circadian variations and chronotherapeutic implications for cardiovascular management: a focus on COER verapamil.Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials.Hypertension syndrome and cardiovascular events. High blood pressure is only one risk factor.On arterial physiology, pathophysiology of vascular compliance, and cardiovascular disease.Myocardial infarction after carotid stenting and endarterectomy: results from the carotid revascularization endarterectomy versus stenting trial.High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study.Race-sex differences in the management of hyperlipidemia: the REasons for Geographic and Racial Differences in Stroke studyCorrelates of Incident Cognitive Impairment in the REasons for Geographic and Racial Differences in Stroke (REGARDS) StudyIs Pulse Pressure an Independent Risk Factor for Incident Stroke, REasons for Geographic And Racial Differences in Stroke.Health knowledge about symptoms of heart attack and stroke in adult survivors of childhood acute lymphoblastic leukemia.Prehypertension, racial prevalence and its association with risk factors: Analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.Subclinical, hemodynamic, and echocardiographic abnormalities of high pulse pressure in hypertensive and non-hypertensive adults.Antihypertensive safety and efficacy and physician and patient satisfaction: results from a phase 4 practice-based clinical experience trial with diltiazem LA.Clinical trial design issues: at least 10 things you should look for in clinical trials.Associations between arterial elasticity and markers of inflammation in healthy older women.Primary prophylactic aspirin use and incident stroke: reasons for geographic and racial differences in stroke study.Systolic blood pressure response after high-intensity interval exercise is independently related to decreased small arterial elasticity in normotensive African American women.Does differential prophylactic aspirin use contribute to racial and geographic disparities in stroke and coronary heart disease (CHD)?Perceived Stress and Atrial Fibrillation: The REasons for Geographic and Racial Differences in Stroke Study.Awareness, treatment, and control of LDL cholesterol are lower among U.S. adults with undiagnosed diabetes versus diagnosed diabetes.Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients.The Global Burden of Cardiovascular Disease: The Role of Endothelial Function and Arterial Elasticity in Cardiovascular Disease as Novel and Emerging BiomarkersRecruitment strategies and challenges in a large intervention trial: Systolic Blood Pressure Intervention Trial.Racial differences in the impact of elevated systolic blood pressure on stroke risk.Smoking, inflammatory patterns and postprandial hypertriglyceridemia.The risks associated with short-term placebo-controlled antihypertensive clinical trials: a descriptive meta-analysis.
P50
Q27026525-5F733FE7-646E-43B3-B21B-2F34F52265A1Q30249292-47ED0143-88BD-4481-8586-3040B46259D8Q30494654-401CDB34-B425-4B91-852D-3A57E705315AQ31065825-B6BCC276-F22F-4DC5-83A3-F8FA776C9ED2Q33585339-E44A3941-5140-46CC-A740-676FC9A18A41Q33760723-9076555F-BCCB-4D7C-A3F4-282B1D685CB1Q33795981-13B3A307-B6D0-4FFB-8F85-BCFEB8031735Q33940584-09553A75-A8E7-492B-BF48-123D0DE7273DQ34028627-BB1664B5-89BD-43E9-B21B-19393FF7E49EQ34057028-A7338543-5912-4F60-A2B4-D7841F75C261Q34078486-4147729D-54DA-4F3E-9AF6-169886214D97Q34090463-57E41C5F-4FC6-42EA-8144-8A97028F0DEBQ34230650-5074962C-1C31-4F98-B20B-9BF5D7056B11Q34423662-0FB9F0F6-8C0D-407F-B241-DF1F9E015C25Q34447318-0C9115AE-A6FC-4FB6-A611-857F0692CB88Q34450426-EB8834F7-FC45-415F-BA19-FA1ADAE80F64Q34452171-4F77F1CE-897C-445F-9EE2-4A40895FF0FBQ34452947-4C80A8BC-E56A-490F-AF83-B1742D26DD45Q35214702-0142E644-D043-422F-AF0E-299F731E3A08Q35509384-6EE41A23-A5DA-43D3-A552-E4270EB4D799Q35575925-B9F7B076-5FA6-472A-B1D8-2BA45A995C95Q35856585-611B1BAD-07A5-4109-9401-6A2FBD47D229Q35974540-CDDC9817-054A-4B64-B99E-13E5533B9777Q36084401-83EEA3B0-8892-49D3-95A8-5D0868CD767BQ36308772-21B969F4-6DD1-4B16-BE45-A199750C2D9DQ36404570-F6020C99-040E-4B27-AAA7-57AA452C1C9AQ36496498-3DF807CD-89D6-479B-9E00-E271D7671FB6Q36599365-5C9A0907-575D-4D94-95A9-881A4771FFC1Q36672175-3D1F46B0-26A7-4C02-843A-DC26B6BA8462Q36850971-52AE0EE4-DA02-4022-A415-095C71252C10Q36863238-353CD1B3-F8A7-47D5-9C90-EE0591B10E85Q36914763-26B20644-82D2-4885-8CEF-70475966737DQ37073581-5114273C-39D6-48ED-8A2E-A403348112B4Q37106411-4B99AEAF-DA19-4C6F-A3AC-3EE695BC7CB6Q37113917-AE6BBD93-FC45-4AFF-9B01-8F20B63F335BQ37136183-8B55EC4D-766C-4911-88D5-07B1FBF9E9F2Q37136348-2112D61E-7626-4AF4-A23A-982F2BDE5B7FQ37137494-07FBB54D-9D0E-42A8-BDD4-A25F71751B12Q37144675-36C1191D-E164-4DC5-B09E-8EA55024AD38Q37182751-B99B5A67-38FB-40CA-9AF2-E8793793F799
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Stephen P Glasser
@ast
Stephen P Glasser
@en
Stephen P Glasser
@es
Stephen P Glasser
@nl
Stephen P Glasser
@sl
type
label
Stephen P Glasser
@ast
Stephen P Glasser
@en
Stephen P Glasser
@es
Stephen P Glasser
@nl
Stephen P Glasser
@sl
prefLabel
Stephen P Glasser
@ast
Stephen P Glasser
@en
Stephen P Glasser
@es
Stephen P Glasser
@nl
Stephen P Glasser
@sl
P214
P5361
P106
P21
P214
P31
P496
0000-0001-9620-6406
P5361
GlasserStephenP1940-
P735
P7859
lccn-n79096661